The IP journal covers a variety of topics of interest to those working in the worldwide pharma industry. This issue is our second special Covid-19 issue.
The journal is published quarterly by Euromed Communications in association with the Industrial Pharmacy Section of the FIP.
Contents include:
COVID-19: Remarkable progress with vaccines and therapeutics
Vaccine vigilance: the key role of adverse event reporting in a high-profile field
Is COVID-19 the long-overdue wake-up call for pharma supply chains? Part 2
The role of Pharmacists in administering the COVID-19 Vaccine.
Pharmaceutical development of early antivirals
The new era of digital innovation in healthcare.